Cas:25301-02-4 Tyloxapol manufacturer & supplier

Chemical Name:Tyloxapol

CAS.NO:25301-02-4

Synonyms:Triton A-20;MFCD00149002;Triton WR 1339;Tyloxypal;4-(1,1,3,3-Tetramethylbutyl)phenol polymer with formaldehyde and oxirane;Alevaire;Superinone;Tyloxapol;Macrocyclon

Molecular Formula:(C₁₅H₂₁O(C₂H₄O)m)n

Molecular Weight:261.38 (monomer)

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:282.3ºC at 760 mmHg

Density:1.1

Index of Refraction:

PSA:49.83000

Exact Mass:

LogP:4.57360

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like Triton A-20 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Macrocyclon physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Triton WR 1339 Use and application,4-(1,1,3,3-Tetramethylbutyl)phenol polymer with formaldehyde and oxirane technical grade,usp/ep/jp grade.

Related News: The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy. Tyloxapol manufacturer Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings. Tyloxapol supplier Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.�� Tyloxapol vendor The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy. Tyloxapol factory Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings.